Company Description
Entero Therapeutics, Inc. designs and develops an artificial intelligence (AI)-driven software and device platform that enables utilities, retailers, and large power users to manage load and distributed energy resources.
The company's Aggregation Management Platform leverages IoT, AI/ML, and edge analytics to forecast, optimize, and dispatch flexible demand.
The company also engages in the research and development of targeted and non-systemic therapies for the treatment of patients with gastrointestinal diseases.
It serves residential and small business, commercial and utility, technology and innovation, and hyperscale industries.
The company is based in Edinburgh, United Kingdom with additional offices in Prague, Czechia; and Mississauga, Canada.
| Country | United Kingdom |
| Founded | 2014 |
| IPO Date | Oct 11, 2016 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 2 |
| CEO | Jason Sawyer |
Contact Details
Address: 91 George St Edinburgh, EH2 3ESL United Kingdom | |
| Website | grid-ai.com |
Stock Details
| Ticker Symbol | ENTO |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001604191 |
| CUSIP Number | 33749P507 |
| ISIN Number | US33749P5070 |
| Employer ID | 46-4993860 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Jason David Sawyer | Interim Chief Executive Officer and Director |
| Anna Skowron | Interim Chief Financial Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Nov 6, 2025 | 8-K | Current Report |
| Oct 31, 2025 | 8-K | Current Report |
| Oct 22, 2025 | 8-K | Current Report |
| Oct 6, 2025 | 8-K | Current Report |
| Sep 17, 2025 | 424B3 | Prospectus |
| Sep 15, 2025 | EFFECT | Notice of Effectiveness |
| Sep 12, 2025 | 8-K | Current Report |
| Sep 10, 2025 | S-1/A | [Amend] General form for registration of securities under the Securities Act of 1933 |
| Sep 9, 2025 | 8-K | Current Report |
| Aug 26, 2025 | S-1 | General form for registration of securities under the Securities Act of 1933 |